This study assessed the technical and programmatic feasibility of a microarray patch for sustained, intradermal delivery of primaquine to treat P. vivax malaria. The team conducted an analysis to assess the potential for using microarray patches for delivery of primaquine and to inform the development of target product profile characteristics.